Qube Research & Technologies (QRT)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Sell
25,400
-45,500
-64% -$4.06M ﹤0.01% 2122
2025
Q4
$5.6M Buy
70,900
+53,500
+307% +$4.19M 0.01% 1703
2025
Q3
$1.39M Sell
17,400
-37,600
-68% -$3.21M ﹤0.01% 2389
2025
Q2
$5M Buy
55,000
+53,600
+3,829% +$4.89M 0.01% 1695
2025
Q1
$131K Buy
1,400
+500
+56% +$44.8K ﹤0.01% 2956
2024
Q4
$81.8K Buy
900
+600
+200% +$57.3K ﹤0.01% 3026
2024
Q3
$31.1K Buy
+300
New +$30.6K ﹤0.01% 2923

Other funds holding CL

Qube Research & Technologies (QRT)'s CL Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Colgate-Palmolive (CL) stake by 647% in Q1 2026, buying an estimated $187M and bringing the position to 2,421,293 shares worth $206M. The position accounts for 0.23% of the portfolio, ranked #92.

Qube Research & Technologies (QRT) first reported a position in CL in Q1 2018 and has held it in 27 quarters since. The position peaked at $406M in Q1 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Qube Research & Technologies (QRT) held 2,421,293 shares of Colgate-Palmolive worth $206M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 2,097,037 Colgate-Palmolive shares in Q1 2026, an estimated $187M.
  • Colgate-Palmolive made up 0.23% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #92 holding.
  • Qube Research & Technologies (QRT) first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 27 quarters since.
  • Qube Research & Technologies (QRT)'s Colgate-Palmolive position peaked at $406M in Q1 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.